New approaches seek to promote e-Rxs


In an ongoing effort to boost the use of electronic medical records, technology vendors are finding more ways to make it easier for physicians to use them. Aiming directly at tech-savvy doctors, Zix Corp. has developed a new version of its PocketScript solution for smart phones-cell phones like Verizon's Samsung i730 Smartphone that also function as PDAs (personal digital assistants).

Other companies are hoping that free access to e-prescribing tools will encourage adoption. Caremark will offer iScribe hardware, software, and on-line tools for free to 10,000 prescribing physicians in seven states. NaviMedix, on the other hand, will offer free e-prescription renewals. The offer is extended to NaviMedix's more than 150,000 providers or any physicians within the company's national service area.

HealthSpring rolls out Zynchros system

HealthSpring is implementing the automated formulary management solution. The Web site offers an end-to-end solution for simplifying regulatory reporting around Medicare Part D and improving the flow of prescription drug benefit information to HealthSpring's members. also has integrated Medi-Span MDDB v2.5 Master Drug Database to provide drug descriptive data at the NDC level within The Web site will be updated weekly. The Medi-Span database provides comprehensive, integrated drug information.

Docs to get drug eligibility info from PBM

CVS' PBM subsidiary PharmaCare announced an agreement with SureScripts to allow physicians using SureScripts certified technology to access information regarding a patient's drug formulary and eligibility-in real time, during the patient's office visit. Putting formulary and eligibility information at a physician's fingertips eliminates many of the questions that often require pharmacists and PBMs to place multiple phone calls to a physician's office. Under a separate agreement, PharmaCare's mail service and specialty pharmacies will also have the ability to receive SureScripts e-prescriptions.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.